Nutrien Stock Forecast, Price & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has increased by 67.4% and is now trading at $53.58.
View which stocks have been most impacted by COVID-19.

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 7 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Nutrien stock.
View analyst ratings for Nutrien or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Nutrien a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nutrien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Nutrien is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Nutrien.

Nutrien Ltd. (NYSE:NTR) posted its earnings results on Monday, November, 2nd. The company reported $0.23 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.07 by $0.16. The firm had revenue of $4.21 billion for the quarter, compared to analysts' expectations of $3.83 billion. Nutrien had a net margin of 0.47% and a return on equity of 4.19%. The business's revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.24 EPS.
View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Thursday, December 10th. Stockholders of record on Thursday, December 31st will be given a dividend of $0.346 per share on Thursday, January 14th. This represents a $1.38 annualized dividend and a yield of 2.58%. The ex-dividend date is Wednesday, December 30th.
View Nutrien's dividend history.

Nutrien pays an annual dividend of $1.80 per share and currently has a dividend yield of 3.38%. Nutrien does not yet have a strock track record of dividend growth. The dividend payout ratio of Nutrien is 82.95%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Nutrien will have a dividend payout ratio of 82.57% in the coming year. This indicates that Nutrien may not be able to sustain their current dividend.
View Nutrien's dividend history.

Nutrien issued an update on its FY 2020 After-Hours earnings guidance on Monday, November, 2nd. The company provided earnings per share guidance of 1.60-1.85 for the period.

20 brokers have issued 1 year price targets for Nutrien's stock. Their forecasts range from $40.00 to $58.00. On average, they expect Nutrien's stock price to reach $49.24 in the next year. This suggests that the stock has a possible downside of 8.1%.
View analysts' price targets for Nutrien or view Wall Street analyst' top-rated stocks.

Nutrien saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 5,300,000 shares, a decrease of 20.2% from the December 15th total of 6,640,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the days-to-cover ratio is currently 3.8 days. Approximately 0.9% of the company's stock are short sold.
View Nutrien's Short Interest.

Some companies that are related to Nutrien include The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), Marrone Bio Innovations (MBII), CVR Partners (UAN), Calyxt (CLXT), Evogene (EVGN), Wynnstay Group Plc (WYN.L) (WYN), Eden Research plc (EDEN.L) (EDEN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET) and SenesTech (SNES).
View all of NTR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by many different institutional and retail investors. Top institutional investors include Livingston Group Asset Management CO operating as Southport Capital Management (0.05%), Hexavest Inc. (0.04%), Crossmark Global Holdings Inc. (0.01%), Raymond James Trust N.A. (0.01%), Pacifica Partners Inc. (0.00%) and DAVENPORT & Co LLC (0.00%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Livingston Group Asset Management CO operating as Southport Capital Management, DAVENPORT & Co LLC, and Huntington National Bank.

NTR stock was acquired by a variety of institutional investors in the last quarter, including Raymond James Trust N.A., Pacifica Partners Inc., Fruth Investment Management, and Crossmark Global Holdings Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $53.58.

Nutrien has a market capitalization of $30.49 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]